Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BUSINESS BITES: Endeavour Eyes More Medtech Plays; M3i Puts Yen In Artificial Heart; Curetis Makes Third mDx Launch

This article was originally published in Clinica

Executive Summary

Endeavour Vision’s fund, Endeavour Medtech Growth LP (EMG), is looking to invest in “high potential” European and US medical device and digital health companies that are starting to take their first steps to commercialize their approved products. Endeavour raised €250m ($275m) for EMG, said to be “the largest fund dedicated to medtech in Europe and one of the largest pure medtech funds worldwide.” The fund will allocate between €10-20m per investment.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT103294

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel